Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Periodontal Disease in Patients Receiving Dialysis.

Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H.

Int J Mol Sci. 2019 Aug 3;20(15). pii: E3805. doi: 10.3390/ijms20153805. Review.

2.

Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.

Kitamura M, Mochizuki Y, Miyata Y, Obata Y, Mitsunari K, Matsuo T, Ohba K, Mukae H, Yoshimura A, Nishino T, Sakai H.

Int J Mol Sci. 2019 Jul 11;20(14). pii: E3413. doi: 10.3390/ijms20143413. Review.

3.

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis.

Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, Nishino T, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Sci Rep. 2019 Jun 27;9(1):9331. doi: 10.1038/s41598-019-45776-x.

4.

Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis.

Kitamura M, Tateishi Y, Sato S, Kitamura S, Ota Y, Muta K, Yamashita H, Uramatsu T, Obata Y, Mochizuki Y, Nishikido M, Izumo T, Harada T, Funakoshi S, Matsuo T, Tsujino A, Sakai H, Mukae H, Nishino T.

BMC Nephrol. 2019 Jun 7;20(1):210. doi: 10.1186/s12882-019-1400-4.

5.

Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels.

Kitamura M, Mochizuki Y, Kitamura S, Mukae Y, Nakanishi H, Ota Y, Muta K, Yamashita H, Obata Y, Iwata T, Nishikido M, Kawanami S, Takashima M, Sasaki H, Sakai H, Mukae H, Nishino T.

Ann Transplant. 2019 May 10;24:260-267. doi: 10.12659/AOT.914909.

6.

Significance of subepithelial deposits in patients diagnosed with IgA nephropathy.

Kitamura M, Obata Y, Ota Y, Muta K, Yamashita H, Harada T, Mukae H, Nishino T.

PLoS One. 2019 Feb 20;14(2):e0211812. doi: 10.1371/journal.pone.0211812. eCollection 2019.

7.

Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.

Japanese Society of Nephrology.

Clin Exp Nephrol. 2019 Jan;23(1):1-15. doi: 10.1007/s10157-018-1648-1. No abstract available.

8.

Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation.

Kitamura M, Hisano S, Kurobe Y, Abe S, Ota Y, Sawayama Y, Uramatsu T, Obata Y, Fukuoka J, Miyazaki Y, Mukae H, Nishino T.

Intern Med. 2019 Jan 1;58(1):91-96. doi: 10.2169/internalmedicine.1251-18. Epub 2018 Aug 24.

9.

A case of mild phenotype Alport syndrome caused by COL4A3 mutations.

Kamijo M, Kitamura M, Muta K, Uramatsu T, Obata Y, Nozu K, Kaito H, Iijima K, Mukae H, Nishino T.

CEN Case Rep. 2017 Nov;6(2):189-193. doi: 10.1007/s13730-017-0273-2. Epub 2017 Aug 30.

10.

A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.

Oka S, Obata Y, Torigoe K, Torigoe M, Abe S, Muta K, Ota Y, Kitamura M, Kawasaki S, Hirose M, Uramatsu T, Yamashita H, Arai H, Mukae H, Nishino T.

Drugs R D. 2017 Sep;17(3):389-396. doi: 10.1007/s40268-017-0188-6.

11.

Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.

Oka S, Obata Y, Sato S, Torigoe K, Sawa M, Abe S, Muta K, Ota Y, Kitamura M, Kawasaki S, Hirose M, Uramatsu T, Mukae H, Nishino T.

Med Sci Monit. 2017 Mar 26;23:1464-1470.

12.

Improvements in Pneumatosis Cystoides Intestinalis and Hepatic Portal Venous Gas with Conservative Therapy in a Patient on Maintenance Dialysis.

Torigoe K, Arai H, Yamashita A, Muraya Y, Obata Y, Nishino T.

Intern Med. 2016;55(13):1735-8. doi: 10.2169/internalmedicine.55.6235. Epub 2016 Jul 1.

13.

Curcumin ameliorates nephrosclerosis via suppression of histone acetylation independent of hypertension.

Muta K, Obata Y, Oka S, Abe S, Minami K, Kitamura M, Endo D, Koji T, Nishino T.

Nephrol Dial Transplant. 2016 Oct;31(10):1615-23. doi: 10.1093/ndt/gfw036. Epub 2016 Mar 24.

PMID:
27190365
14.

Evidence-based clinical practice guidelines for nephrotic syndrome 2014.

Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, Kiyomoto H, Goto S, Konta T, Sasatomi Y, Sato Y, Nishino T, Tsuruya K, Furuichi K, Hoshino J, Watanabe Y, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Jun;20(3):342-70. doi: 10.1007/s10157-015-1216-x. Review. No abstract available.

15.

Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation.

Abe S, Obata Y, Oka S, Koji T, Nishino T, Izumikawa K.

Med Mol Morphol. 2016 Sep;49(3):144-53. doi: 10.1007/s00795-016-0133-8. Epub 2016 Feb 15.

PMID:
26880269
16.

Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.

Ichinose K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Arima K, Nakamura H, Obata Y, Yamamoto K, Origuchi T, Nishino T, Kawakami A, Tsokos GC.

Arthritis Rheumatol. 2016 Apr;68(4):944-52. doi: 10.1002/art.39499.

17.

A case of membranoproliferative glomerulonephritis and AA amyloidosis complicated with pulmonary nontuberculous mycobacterial infection.

Tsuji K, Arai H, Furusu A, Torigoe K, Tokuyama A, Muraya Y, Nakashima M, Taguchi T, Obata Y, Nishino T, Kohno S.

CEN Case Rep. 2015 May;4(1):24-30. doi: 10.1007/s13730-014-0134-1. Epub 2014 Jul 9.

18.

The kampo medicine Daikenchuto inhibits peritoneal fibrosis in mice.

Kitamura M, Nishino T, Obata Y, Oka S, Abe S, Muta K, Ozono Y, Koji T, Kohno S.

Biol Pharm Bull. 2015;38(2):193-200. doi: 10.1248/bpb.b14-00469.

19.

New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models.

Kitamura M, Nishino T, Obata Y, Ozono Y, Koji T, Kohno S.

Acta Histochem Cytochem. 2014 Aug 29;47(4):133-43. doi: 10.1267/ahc.14025. Epub 2014 Jul 16.

20.

Three cases of concurrent infection with Mycobacterium tuberculosis and Cryptococcus neoformans.

Kakeya H, Izumikawa K, Yamada K, Obata Y, Nishino T, Takazono T, Kosai K, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Tashiro T, Kohno S.

Intern Med. 2014;53(15):1685-92. Epub 2014 Aug 1.

Supplemental Content

Loading ...
Support Center